Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial*-Reference-Cited by-同舟云学术

Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial*

Published:2009-01 Issue:1 Volume:24 Page:153-161
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:Journal of Bone and Mineral Research

Author:

Brown Jacques P,Prince Richard L,Deal Chad,Recker Robert R,Kiel Douglas P,de Gregorio Luiz H,Hadji Peyman,Hofbauer Lorenz C,Álvaro-Gracia Jose M,Wang Huei,Austin Matthew,Wagman Rachel B,Newmark Richard,Libanati Cesar,San Martin Javier,Bone Henry G

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference32 articles.

1. Osteoporosis Prevention, Diagnosis, and Therapy

2. Trends in HRT and anti-osteoporosis medication prescribing in a European population after the WHI study

3. National Trends in Osteoporosis Visits and Osteoporosis Treatment, 1988-2003

4. Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005

5. Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis

Cited by 398 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of denosumab in osteoporosis – an update on efficacy and drug safety;Expert Opinion on Drug Safety;2024-09-11

2. Cardiovascular Safety of Romosozumab Compared to Commonly Used Anti-osteoporosis Medications in Postmenopausal Osteoporosis: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials;Drug Safety;2024-09-03

3. Efficacy and safety of denosumab and teriparatide versus oral bisphosphonates to treat postmenopausal osteoporosis: a systematic review and meta-analysis;Frontiers in Endocrinology;2024-09-02

4. Anti-RANKL Antibody For Active Charcot Foot Neuro-Osteoarthropathy in Patients with Diabetes and Chronic Kidney Disease;Foot & Ankle International;2024-08-26

5. RANK–RANKL–OPG Axis in MASLD: Current Evidence Linking Bone and Liver Diseases and Future Perspectives;International Journal of Molecular Sciences;2024-08-24